Analyst Expectations for Kura Oncology's Future
Portfolio Pulse from Benzinga Insights
Analysts have provided bullish and somewhat bullish ratings for Kura Oncology (NASDAQ:KURA) in the last quarter. The average price target for KURA is $26.31, indicating a potential upside from its current price of $9.77. The average price target has increased by 9.62% over the past month.
September 07, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have provided bullish ratings for Kura Oncology, indicating a potential upside for the stock.
The bullish ratings from analysts indicate a positive outlook for Kura Oncology. The average price target of $26.31, which is significantly higher than the current price of $9.77, suggests that analysts expect the stock price to rise in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100